Frontier Biotechnologies Inc. (SHA:688221)
15.54
+0.64 (4.30%)
At close: Sep 18, 2025
Frontier Biotechnologies Revenue
Frontier Biotechnologies had revenue of 30.31M CNY in the quarter ending June 30, 2025, with 14.78% growth. This brings the company's revenue in the last twelve months to 137.06M, up 11.55% year-over-year. In the year 2024, Frontier Biotechnologies had annual revenue of 129.47M with 13.32% growth.
Revenue (ttm)
137.06M
Revenue Growth
+11.55%
P/S Ratio
42.47
Revenue / Employee
261.56K
Employees
302
Market Cap
5.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 129.47M | 15.22M | 13.32% |
Dec 31, 2023 | 114.25M | 29.51M | 34.82% |
Dec 31, 2022 | 84.74M | 44.24M | 109.22% |
Dec 31, 2021 | 40.50M | -6.12M | -13.13% |
Dec 31, 2020 | 46.62M | 25.76M | 123.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |